| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483928A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use |
| 05/06/1992 | EP0483881A1 3-Amidoindolyl derivatives |
| 05/06/1992 | EP0483765A2 Method for activating lymphocyte |
| 05/06/1992 | EP0483643A2 Use of macrophage colony-stimulating factor in the treatment of cachexia |
| 05/06/1992 | EP0483634A2 An aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside |
| 05/06/1992 | EP0483271A1 Peptides containing diamino-glycols as transition-state mimics. |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0453515A4 Composition and method for treatment of senile dementia |
| 05/06/1992 | EP0278977B1 Prodrug derivatives of carboxylic acid drugs |
| 05/05/1992 | US5110936 Condensation of pyroglutamic acid with ethyl ester of 4-thiazolidinecarboxylic acid |
| 05/05/1992 | US5110925 Cardiotonic agents |
| 05/05/1992 | US5110808 Amide derivatives, compositions and use |
| 05/05/1992 | US5110796 Prophylactic and therapeutic agents for cataracts |
| 05/05/1992 | US5110720 Treating caries and healing acute inflammations, antiosteoporotic agent, antiphlogistic agent |
| 05/05/1992 | CA1300313C2 Amino acid derivatives |
| 05/05/1992 | CA1300170C Process for intermediates to leukotriene antagonists |
| 05/05/1992 | CA1300169C Process for intermediates to leukotriene antagonists |
| 05/05/1992 | CA1300150C 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives |
| 05/03/1992 | WO1992007558A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/03/1992 | WO1992007557A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
| 05/03/1992 | CA2072889A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
| 05/03/1992 | CA2072884A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 05/02/1992 | WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 05/02/1992 | CA2054653A1 Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use therefor |
| 05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
| 05/01/1992 | CA2052246A1 Lithium treatment |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992006975A1 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 04/30/1992 | WO1992006974A1 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 04/30/1992 | WO1992006973A1 Indole derivatives |
| 04/30/1992 | WO1992006960A1 Piperazine derivatives |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2071940A1 Piperazine derivatives |
| 04/29/1992 | EP0482498A2 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | EP0481994A1 Metallo-organic cobalt compounds and uses thereof |
| 04/29/1992 | CN1060655A 4-or 5-substituled pyridine-2-carboxylic acids process for preparation thereof and use therof as pharmaceuticals |
| 04/29/1992 | CN1060653A Crystallization of optical isomers of leukotriene antagonists |
| 04/28/1992 | US5109021 Prostaglandin analogues, process for their preparation and pharmaceutical compositions containing them |
| 04/28/1992 | US5109001 Treating hyperactivity of excitatory neurotransmitters |
| 04/28/1992 | US5108989 Administering transfurming growth factor-beta prior to tissue damage |
| 04/28/1992 | US5108758 Glassy amylose and a therapeutical or diagnostically active compound; for treating ulcerative colitis, crohm's desease and cancer of colon |
| 04/22/1992 | EP0481920A1 Benzoheterocyclylalkylaminoalkane diphosphonic acids |
| 04/22/1992 | EP0481802A1 Hydroxylated inhibitors of HIV reverse transcriptase |
| 04/22/1992 | EP0481790A2 Antibody production |
| 04/22/1992 | EP0481708A1 Indenoindole compounds |
| 04/22/1992 | EP0481671A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 04/22/1992 | EP0481522A1 Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 04/22/1992 | EP0481207A1 Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 04/22/1992 | EP0481000A1 Receptors for fibroblast growth factors |
| 04/22/1992 | EP0480950A1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 04/22/1992 | EP0480918A1 Reduced size lhrh analogs |
| 04/22/1992 | CN1060464A 4,5-substituted pyridine-2-carboxylic acids, process for preparation thereof and use thereof as pharmaceuticals |
| 04/21/1992 | US5106981 Skin disorders |
| 04/21/1992 | US5106978 Process and intermediates for the preparation of spiro(isoquinoline-4(1H), 3'-pyrrolidine)-1,2', 3,5'(2H)-tetrones which are useful as aldose reductase inhibitors |
| 04/21/1992 | US5106858 For disfunction of heart, brain, lung or kidney |
| 04/21/1992 | US5106850 Hypotensive agents, antidepressants, psychological disoders, migraines |
| 04/21/1992 | US5106847 Excitatory amino acid antagonists, compositions and use |
| 04/21/1992 | US5106843 Treatment of migraine, emesis, anxiety, gastrointestinal disorders, psychological disorders |
| 04/21/1992 | US5106626 Proteins isolated from bones |
| 04/21/1992 | US5106616 Administration of acemannan |
| 04/21/1992 | CA1299178C Heterocyclic oxophtalazinyl acetic acids |
| 04/21/1992 | CA1299126C Hirudin-pa and its derivatives |
| 04/20/1992 | WO1992006687A1 Novel 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 04/20/1992 | CA2052014A1 Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 04/19/1992 | CA2053599A1 Benzoheterocyclylalkylaminoalkanediphosphonic acids |
| 04/19/1992 | CA2053512A1 Hydroxylated inhibitors of hiv reverse transcriptase |
| 04/18/1992 | WO1992006977A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| 04/18/1992 | CA2071911A1 P-substituted derivatives of phenyl 4-oxybutane amine, processes for preparation thereof, and pharmaceutical compositions holding same |
| 04/18/1992 | CA2053650A1 Endothelin precursors, genes and receptors |
| 04/17/1992 | WO1992006956A1 Indenoindole compounds |
| 04/17/1992 | CA2094024A1 Indenoindole compounds |
| 04/16/1992 | WO1992006090A1 Epoxysuccinamic acid derivative |
| 04/16/1992 | WO1992006082A1 Piperazine derivatives |
| 04/16/1992 | WO1992006075A1 Anti-atherosclerotic aryl compounds |
| 04/16/1992 | WO1992005784A1 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
| 04/16/1992 | WO1992004015A3 Regulation of t-cell proliferation via a novel 5ht1a receptor |
| 04/16/1992 | WO1992002240A3 Novel methods and compositions for treatment of angiogenic diseases |
| 04/16/1992 | CA2070173A1 Piperazine derivatives |
| 04/16/1992 | CA2052973A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 04/15/1992 | EP0480717A1 Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480716A1 Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/15/1992 | EP0480711A1 Inhibitors of HIV protease |
| 04/15/1992 | EP0480708A2 Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/1992 | EP0480691A2 Combination therapy for peptic ulcer treatment |
| 04/15/1992 | EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia |
| 04/15/1992 | EP0480641A1 Tricyclic heterocycles |
| 04/15/1992 | EP0480455A1 Optically active thienotriazolodiazepine compounds |
| 04/15/1992 | EP0480315A2 Use of a retinoid |
| 04/15/1992 | EP0480257A2 Use of a potassium channel activator for pharmaceutical compositions useful in cardiopulmonary bypass and organ transplant |
| 04/15/1992 | EP0480204A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor |
| 04/15/1992 | EP0480152A1 KS-505 derivatives |
| 04/15/1992 | EP0479948A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 04/15/1992 | EP0479912A1 Inhibition of the n-end rule pathway in living cells. |
| 04/15/1992 | EP0479910A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp-Phe- AND PHENETHYLAMINE DERIVATIVES |